Fundraising FoxNascent Biotech
Burnsville, US
Find your way into Nascent Biotech
Sign up to see every warm intro you have to Nascent Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nascent Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nascent Biotech develops proprietary human monoclonal antibodies and immunotherapy for cancer treatment, with a lead therapeutic asset (Pritumumab) validated in brain cancer patients. The company is pursuing novel targets with a broad pipeline of therapies and diagnostics, supported by platform drug delivery technology.
Founders & leadership
LH
Lowell HoldenChief Financial Officer
SC
Sean CarrickChief Executive Officer
BP
Brandon PriceExecutive
MG
Mark GlassyExecutive
Reported raises · per SEC filings
Form D private placements$542.5K disclosed across 1 of 2 rounds · 2014–2020
▶$542.5KraisedOct 2014 · 22 investors · BiotechnologyRule 506(b)
▶$542.5KraisedOct 2014 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lowell HoldenExecutive Officer, Director
- Sean CarrickExecutive Officer, Director
- Brandon PriceExecutive Officer, Director
- Mark GlassyExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $542.5K
- Minimum investment
- $10K
- First sale
- Mar 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Nascent Biotech do?
- Nascent Biotech develops proprietary human monoclonal antibodies and immunotherapy for cancer treatment, with a lead therapeutic asset (Pritumumab) validated in brain cancer patients. The company is pursuing novel targets with a broad pipeline of therapies and diagnostics, supported by platform drug delivery technology.
- How much funding has Nascent Biotech raised?
- Nascent Biotech has disclosed $542.5K raised across 1 of its 2 known rounds.
- Where is Nascent Biotech headquartered?
- Nascent Biotech is headquartered in Burnsville, US.